Cell Impact AB (CI) AI Stock Analysis

• Market Cap: kr51.55M
• Dividend Yield: N/A
• Average Volume (3M): 4.50M
• Price to Earnings (P/E): ―
• Beta (1Y): 1.16
• Revenue Growth: -81.35%
• EPS Growth: 42.35%
• Country: SE
• Employees: 41
• Sector: Industrials
• Sector Strength: 72
• Industry: Manufacturing - Metal Fabrication
• EPS (TTM): -0.14
• Shares Outstanding: 294,584,750
• 10 Day Avg. Volume: 6,494,872
• 30 Day Avg. Volume: 4,501,845
• PEG Ratio: 0.10
• Price to Book (P/B): 4.03
• Price to Sales (P/S): 23.68
• P/FCF Ratio: -11.53
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 40 Underperform
• Price Target: kr0.24 ▼(-9.62% Downside)

Cell Impact AB's overall stock score is primarily impacted by its poor financial performance, with significant losses and cash flow issues. The technical analysis further indicates a bearish trend, and the valuation metrics highlight the company's unprofitability. These factors collectively result in a low stock score, suggesting high risk and limited investment appeal.

Positive Factors

Industry Growth Potential

The renewable energy sector, particularly hydrogen fuel cells, is poised for growth, offering Cell Impact AB opportunities to expand its market presence and revenue streams.

Product Innovation

Cell Impact AB's focus on innovative fuel cell components positions it well to capture market share as demand for efficient, sustainable energy solutions rises.

Strategic Partnerships

Strategic partnerships with OEMs and industry players enhance Cell Impact AB's market reach and provide stable revenue channels, supporting long-term growth.

Negative Factors

Revenue Decline

A significant decline in revenue indicates challenges in market demand or competitive positioning, threatening long-term financial health and growth prospects.

Profitability Issues

Persistent unprofitability undermines Cell Impact AB's ability to reinvest in growth and innovation, potentially limiting its competitive edge in the long term.

Cash Flow Challenges

Ongoing cash flow challenges restrict operational flexibility and may hinder the company's ability to fund strategic initiatives or weather economic downturns.

Cell Impact AB Business Overview & Revenue Model

Company Description

Cell Impact AB (CI) is a Swedish company specializing in the development and production of advanced fuel cell components, primarily focusing on bipolar plates for hydrogen fuel cells. The company operates within the renewable energy sector, aiming to contribute to the transition towards sustainable energy solutions. CI's core products include innovative flow plates that enhance the efficiency and performance of fuel cells, catering to various applications such as transportation, stationary power generation, and backup power systems.

How the Company Makes Money

Cell Impact AB generates revenue primarily through the sale of its fuel cell components, particularly its proprietary bipolar plates. The company engages in contracts with manufacturers and suppliers in the automotive and energy sectors, providing them with high-quality, efficient components that are crucial for the operation of hydrogen fuel cells. Key revenue streams include direct sales to OEMs (original equipment manufacturers) and partnerships with companies in the hydrogen and fuel cell industries. Additionally, CI may benefit from research and development agreements, as well as potential collaborations with governmental and research institutions focused on advancing hydrogen technology. The growing demand for clean energy solutions and increased investment in hydrogen infrastructure further contribute to the company's earnings potential.

Cell Impact AB Financial Statement Overview

Summary

Cell Impact AB faces significant financial challenges, with declining revenues, negative profitability, and cash flow issues. The balance sheet remains relatively stable, but the company's operational inefficiencies and liquidity concerns pose substantial risks. Strategic improvements in cost management and revenue generation are crucial for financial recovery.

Income Statement

Cell Impact AB's income statement reveals significant challenges, with negative net profit margins and declining revenue. The TTM data shows a drastic revenue drop of 64.75%, and gross profit margins have deteriorated significantly. The company is struggling with profitability, as indicated by negative EBIT and EBITDA margins, reflecting operational inefficiencies and cost management issues.

Balance Sheet

The balance sheet shows moderate leverage with a debt-to-equity ratio of 0.14, indicating a conservative approach to debt. However, the return on equity is negative, reflecting the company's inability to generate returns for shareholders. The equity ratio remains stable, suggesting a solid capital structure, but the negative ROE highlights profitability concerns.

Cash Flow

Cash flow analysis indicates negative operating and free cash flows, with a declining trend in free cash flow growth. The operating cash flow to net income ratio is negative, suggesting cash flow issues. Despite a positive free cash flow to net income ratio, the overall cash flow position is weak, highlighting liquidity challenges.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	6.70M	37.33M	47.26M	76.81M	71.35M	29.31M
Gross Profit	-5.30M	5.42M	25.45M	36.94M	34.88M	19.14M
EBITDA	-68.35M	-66.52M	-97.72M	-86.22M	-68.84M	-37.29M
Net Income	-104.42M	-100.43M	-121.40M	-104.22M	-79.85M	-44.26M
Balance Sheet
Total Assets	216.69M	261.25M	381.93M	401.51M	238.72M	242.88M
Cash, Cash Equivalents and Short-Term Investments	6.67M	20.39M	99.89M	164.67M	28.56M	151.93M
Total Debt	21.44M	30.92M	42.75M	44.70M	19.51M	21.98M
Total Liabilities	29.21M	42.16M	78.56M	77.17M	96.10M	40.99M
Stockholders Equity	187.48M	219.08M	303.37M	324.35M	142.63M	201.89M
Cash Flow
Free Cash Flow	-54.25M	-76.66M	-152.75M	-174.32M	-140.39M	-69.64M
Operating Cash Flow	-50.13M	-62.23M	-100.97M	-105.93M	-86.08M	-47.59M
Investing Cash Flow	100.00K	-14.43M	-51.78M	-68.40M	-54.32M	-21.96M
Financing Cash Flow	38.62M	-2.84M	88.09M	310.47M	17.01M	204.57M

Cell Impact AB Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.26
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Positive
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:CI, the sentiment is Negative. The current price of 0.26 is below the 20-day moving average (MA) of 0.31, below the 50-day MA of 0.36, and below the 200-day MA of 0.32, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 23.51 is Positive, neither overbought nor oversold. The STOCH value of 12.11 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:CI.

Cell Impact AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
PCELL	52 Neutral	kr1.79B	-288.08	-1.63%	―	36.59%	91.88%
TRANS	48 Neutral	kr343.18M	-3,473.91	0.35%	―	10.36%	-100.68%
AXOLOT	43 Neutral	kr88.96M	-9.07	-17.60%	―	-27.29%	72.72%
CI	40 Underperform	kr51.55M	-0.19	―	―	-81.35%	42.35%
SALT.B	39 Underperform	kr870.76M	-12.46	-40.77%	―	11.85%	6.39%
BOMILL	36 Underperform	kr66.29M	-3.18	-115.02%	―	-65.29%	-33.93%